The NR4A1 receptor is pro-oncogenic, regulates ROS/ER stress pathways, and inactivation of the receptor represents a novel pathway for inducing cell death in pancreatic cancer.
INTRODUCTION
Nuclear receptor (NR) superfamily genes are critical regulators of homeostasis at all stages of development (1) , and the 48 human NRs include the endocrine receptors, adopted orphan receptors, and orphan receptors. The NR4A orphan receptor subfamily consists of three orphan receptors (2, 3) , namely NR4A1, (Nur77, TR3, NGFI-B), NR4A2 (Nurr1) and NR4A3 (Nor1), that were initially identified as immediate-early response genes induced by nerve growth factor in PC12 cells (4) . The well-conserved DNA binding and C-terminal ligand binding domains of the NR4A receptors exhibit ~91-95% and ~60% homology, respectively, whereas their N-terminal A/B domains are highly divergent (5-7).
NR4A1 and NR4A2 bind as monomers and homodimers to NGFI-B response elements (NRBE) and Nur-responsive elements (NuRE), respectively. NR4A1 and NR4A2 (but not NR4A3) also form heterodimers with RXR and bind a DRE motif (8) (9) (10) . NR4A receptors are induced by multiple stimuli/stressors and play essential roles in metabolic processes, inflammation, vascular function, steroidgenesis, and in the central nervous system. NR4A1 and NR4A2 are also overexpressed in multiple tumors and cancer cell lines (11, 12) . RNA interference (RNAi) has been used to investigate the role of NR4A1 in cancer cells, and most studies indicate prooncongenic function where NR4A1 enhances both cancer cell proliferation and survival (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) .
Zhang has summarized studies on a novel drug-dependent pro-apoptotic pathway in some cancer cell lines that is dependent on the nuclear export of NR4A1 and the subsequent formation of a mitochondria-associated NR4A1/bcl-2 pro-apoptotic complex (21) . This has also led to development of peptide mimics that convert bcl-2 into an apoptotic complex, and paclitaxel, the taxane-derived anticancer drug, also exhibits comparable activity (22, 23 Multiple anticancer drugs and other apoptosis-inducers activate nuclear export of NR4A1, and there are reports that cytosporone B (CsnB) and related analogs may activate nuclear NR4A1 and also induce nuclear export of this receptor (24) .
Knockdown of NR4A1 in lung and pancreatic cancer cell lines inhibits cell growth and induces apoptosis which is due, in part, to downregulation of the anti-apoptotic gene survivin (19) . Mechanistic studies showed that survivin expression is regulated by a p300/NR4A1/Sp1 complex bound to the proximal GC-rich sites of the survivin promoter (19) . NR4A1 also binds and inactivates wild-type p53 (25) , and NR4A1 silencing results in mTOR inhibition due to activation of p53 and p53-dependent induction of sestrin2 which in turn activates AMPKα (20) .
1,1-Bis(3'-indolyl)-1-(p-hydroxyphenyl)methane (DIM-C-pPhOH) has been characterized as an NR4A1 antagonist which mimics the effects of NR4A1 silencing. DIM-C-pPhOH decreased cancer cell and tumor growth, activated p53-dependent inhibition of mTOR signaling, and downregulated survivin expression (19, 20) .
NR4A1 silencing or treatment with DIM-C-pPhOH also altered pancreatic cancer cell morphology and fragmented the endoplasmic reticulum which is typically observed in cells undergoing endoplasmic reticulum (ER) stress. Results of this study show that NR4A1 regulates reactive oxygen species (ROS) production and expression of genes such as thioredoxin domain containing 5 (TXNDC5) that maintain stress levels that are permissive for cancer cell growth and survival, and both chemical and RNAi-mediated inactivation of NR4A1 induce ER stress and death pathways in pancreatic cancer cells. Proteins altered over 1.5-fold were considered to be significantly changed (p > 0.01 by MannWhitney test). The differentially expressed proteins were cut and digested, and dried sample were desalted with C18 Zip tips (Millipore, Billerica, MA, USA) and were resuspended in 100 μl of an aqueous solution containing 5% acetic acid and 5% acetonitrile for LC-MS/MS analysis.
Each sample solution was loaded onto a 0.1 -150-mm Magic C18AQ reverse phase column (Michrom Bioresources, Inc., Auburn, CA, USA) in line after a nanotrap column using the Paradigm MS4 HPLC system (Michrom Bioresources, Inc.). Separation of the peptides was performed at 500 nl/min and was coupled to on-line analysis by tandem mass spectrometry using an LTQ ion trap mass spectrometer (ThermoElectron, Waltham, MA, USA) equipped with a nanospray ion source (ThermoElectron). The peptides were detected in positive ion mode using a data-dependent method in which the seven most abundant ions detected in an initial survey scan were selected for MS/MS analysis. The MS/MS spectra of 2D samples were searched with Mascot Daemon (Matrix Science, Boston, MA, USA). The following MASCOT parameter settings were used: the peptide tolerance was 15 ppm and peptide charges and the MS/MS tolerance was 0.6 Da. One missed cleavages by trypsin were allowed, carbamidomethyl (C) was used as a fixed modification and oxidation (M) was used as variable modifications.
When multiple proteins were identified in a single spot, the proteins with the highest number of peptides were considered as those corresponding to the spot, and the proteins with lower but significant scores were also recorded in the database.
Transmission electron microscopy. Cells were collected and fixed in 3% glutaraldehyde plus 2% paraformaldehyde in PBS for 2 hr, post-fixed with 1% OsO 4 for 2 hr, and stained for 1 hr in 1% aqueous uranyl acetate. The samples were then dehydrated with increasing concentrations of ethanol, infiltrated, and embedded in Spurr's low viscosity medium. Ultrathin sections were cut using a Leica Ultracut microtome (Leica, Deerfield, IL), counterstained with uranyl acetate and lead citrate in a Leica EM Stainer, and examined under a JEM 1010 transmission electron microscope (JEOL USA Inc., Peabody MA).
Transfection, siRNA oligonucleotides, and reporter gene assay. Cells were transfected with 100 nM of each siRNA duplex for 6 hr using LipofectAMINE 2000 reagent (Invitrogen, Carlsbad, CA, USA), following the manufacturer's protocol. The sequences of siNR4A1 oligonucleotides used were 5'-CAG UCC AGC CAU GCU CCU C dTdT-3'. As a negative control, a nonspecific scrambled small inhibitory RNA (siScr) oligonucleotide was used (Qiagen) and all other siRNAs were purchased from Santa Cruz Biotechnology (Dallas, Texas). Reporter gene assays were performed as previously described (20) . Isolation of RNA and microarray analysis. Total RNA was extracted from Panc-1 cells by using a mirVanaTM miRNA isolation labeling kit (Ambion Inc., Austin, TX, USA). The total RNA was quantified by using a Nanodrop ND-1000 spectrophotometer (NanoDrop Technology, Wilmington, DE, USA). The total RNA samples with adequate RNA quality index (>7) were used for microarray analysis. Sample labeling was performed with an RNA amplification kit according to the manufacturer's instructions (Applied Biosystems, Foster City, CA, USA). We used 700 ng of total RNA for labeling and hybridization on HumanHT-12 v4 expression beadchip (Illumina Inc., San Diego, CA, USA) according to the manufacturer's protocols (Illumina). After the bead chips were scanned with a BeadArray Reader (Illumina), the microarray data were normalized using the quantile normalization method in the Linear Models for Microarray Data (LIMMA) package in the R language (http://www.r-project.org). BRB-ArrayTools were primarily used for statistical analysis of gene expression data and the t-test was applied to identify the genes significantly different between two groups when compared. Cluster analysis was performed using the software programs Cluster and Heatmap was generated by Treeview. oligonucleotide containing the identical consensus sequence as the capture probe was used as a competitor. A negative control without the capture probe was also used in each assay. The ChIP assay was performed using ChiP-IT Express Magnetic Chromatin Immunoprecipitation kit (Active Motif, Carlsbad, CA, USA) as previously described (20) . The TXNDC5 primers which contain the NBRE were 5'-CTA ATT CAG GTG CAA ACC CCA CC -3' (sense) and 5'-AGC GGC GGT GAA CAC ACG AAG TA -3' (antisense).
DNA-binding assay and chromatin immunoprecipitation (
Statistical analysis. Statistical significance of differences between groups were analyzed using Student's t-test. The results are expressed as means with error bars representing 95% confidence intervals for three experiments for each group unless otherwise indicated, and a P value of less than 0.05 was considered statistically significant. All statistical tests were twosided.
RESULTS

Inactivation of NR4A1 induces ER stress and apoptosis
Silencing NR4A1 or inactivation of the receptor by DIM-C-pPhOH inhibited pancreatic cancer cell and tumor growth through decreased expression of some NR4A1-regulated prosurvival genes such as survivin (19) . In this study, we have used a proteomic and gene array approach to identify other key genes regulated by this receptor. Silencing of NR4A1 by RNA interference (RNAi, siNR4A1) followed by two-dimensional gel electrophoresis (Fig. 1A) and mass spectrometry analysis of individual spots, identified 38 proteins induced or suppressed by >2-fold (Suppl. Table 2 ). The functional distribution (Fig. 1B ) and canonical pathways (Fig. 1C) resulting from NR4A1 knockdown demonstrate that this receptor plays a key role in regulating ER stress in Panc-1 cells and this represents a hitherto unknown function for this receptor. Figure 1D illustrates that after knockdown of NR4A1 in Panc-1 cells, there is increased intensity of gel spots identified by mass spectrometry as GRP78 and ERp60, two ER chaperone proteins, and decreased expression of the mitochondrial ATP5A1 and cytosolic PGK1 proteins. In a separate experiment, western blot analysis of whole cell lysates from Panc-1 cells transfected with siNR4A1 or siScr (non-specific oligonucleotide) confirmed induction of the ER stress markers (GRP78 and ERp60) and downregulation of ATP5A1 and PGK1 (Fig. 1D) .
The novel observation that NR4A1 regulates stress in pancreatic cancer cells was further confirmed in Panc-1 cells transfected with siNR4A1 and examined by transmission electron microscopy ( Fig. 2A) . The results show that typical structural features of the ER are disrupted and fragmented. Western blot analysis of Panc-1 cell lysates after NR4A1 silencing confirmed the induction of several ER stress markers including ATF4, XBP-1s, GRP78 and CHOP (Fig. 2B) .
Moreover, NR4A1 silencing also resulted in induction of apoptosis as evidenced by induction of cleaved caspases 8, 3 and 7 and PARP and decreased expression of Bid (p20) (Fig. 2B) , and these responses are typically observed after induction of ER stress (26) (27) (28) . NR4A1 silencing in L3.6pL pancreatic cancer cells also induced ER stress (p-PERK, ATF4, XBP-1s and CHOP) and apoptosis (cleaved caspase-8 and PARP) (Fig. 2C) , and NR4A1 silencing in MCF-7 breast and RKO colon cancer cells (Fig. 2D) (also MDA-MB-231 and Jurkat cells, data not shown) confirmed that this receptor also regulated ER stress in several cancer cell lines. Moreover, tumor lysates from mice treated with corn oil (control) or DIM-C-PhOH (30 mg/kg/d) (19) also showed enhanced expression of ER stress markers in the latter group (Suppl. Fig. S1A ).
Since CHOP is a key stress-induced pro-apoptotic protein, we further investigated the role of CHOP in mediating the effects of NR4A1 silencing in Panc-1 cells (Fig. 3A) . Knockdown of 
NR4A1 enhanced activation of caspases 8 and 7 (cleaved) and PARP cleavage and, in cells transfected with siNR4A1, the pro-apoptotic responses were attenuated in cells cotransfected with siCHOP. These results confirm a role for CHOP and ER stress in mediating siNR4A1-induced apoptosis. We also observed that both siNR4A1 and DIM-C-pPhOH induce LC3-II, a marker of autophagy and siCHOP attenuated this response (Suppl. Figs. S1B and S1C), indicating that CHOP plays a role in ER stress-induced autophagy as previously reported (29).
Inactivation of NR4A1 induces ROS
ROS is an important inducer of ER stress, and therefore we examined the effects of NR4A1 silencing on induction of ROS using the cell permeant dichloroflurescein diacetate (DFC-DA) probe and observed that cells transfected with siNR4A1 exhibited significantly induced ROS which was inhibited after cotreatment with glutathione (GSH) (Fig. 3B) . Moreover, in Panc-1 cells transfected with siScr or siNR4A1, the induction of ER stress (p-PERK, XBP-1s and CHOP) and apoptosis (cleaved caspases 8 and 7 and PARP) markers after NR4A1 silencing were partially reversed after cotreatment with GSH (Fig. 3C) . The role of NR4A1 silencing in inducing ROS-dependent ER stress was also confirmed in L3.6pL pancreatic cancer cells in which transfection with siNR4A1 increased markers of ER stress (p-PERK, XBP-1s, ATF4 and CHOP) and apoptosis (cleaved caspase 8 and PARP) and these responses were attenuated by cotreatment with GSH (Fig. 3D) .
Previous studies have shown that DIM-C-PhOH acts as an NR4A1 antagonist and mimics the effects of NR4A1 silencing (19, 20) , and Figure 4A shows DIM-C-pPhOH significantly increased expression of markers of ER stress (ATF4, XBP-1s and CHOP) and apoptosis (Fig. 4A) which was comparable to the effects of siNR4A1 (Fig. 2B) . Moreover, using a quantitative DNA fragmentation assay (Suppl. Fig. S2A ), we showed that both siNR4A1 and DIM-C-PhOH significantly induced DNA damage, and both treatments also increased ER calcium flux (Suppl. (Fig. 4B) . Moreover, like NR4A1 silencing, inactivation of this receptor by DIM-C-pPhOH also induced ROS which was attenuated after cotreatment with GSH (Fig. 4C) , and DIM-CpPhOH-induced markers of ER stress (CHOP, ATF4, XBP-1s and CHOP) and apoptosis (cleaved caspases 8 and 7 and PARP) were also decreased after cotreatment with GSH (Fig. 4D ).
Inactivation of NR4A1 induces genes involved in ROS metabolism
Thus, siNR4A1 or inactivation of NR4A1 by DIM-C-pPhOH induced ROS-dependent ER stress, and identification of NR4A1-regulated genes involved in ROS metabolism was further investigated by RNAi using Illumina beadchip arrays (Fig. 5A and Suppl. Table 3 ) and several canonical pathways were also affected (Suppl. Fig. S3 ). Only three potential NR4A1-regulated genes involved in ROS metabolism were decreased in Panc-1 cells, namely, IDH1, GLRX and TXNDC5, and in a separate experiment, we confirmed by real time PCR that these genes are regulated by NR4A1 (Fig. 5A) . The potential roles of the NR4A1-regulated IDH1, GLRX and TXNDC5 in mediating ER stress were investigated by RNAi (Fig. 5B) . GLRX protein expression was minimal and ER stress genes were not induced by siGLRX; however, knockdown of IDH1 induced CHOP and cleaved caspase 8 and PARP and this was accompanied by induction ROS (Fig. 5C ). We also observed that silencing of TXNDC5 by RNAi (siTXNDC5) resulted in the induction of ROS which was attenuated after cotreatment with GSH; transfection of Panc-1 cells with siTXNDC5 also induced expression of ATF4, CHOP, cleaved caspase 8 and PARP and these responses were attenuated in cells transfected with siScr or siTXNDC5 and cotreated with 4 mM GSH (Fig. 5D) . Thus, both TXNDC5 and IDH1 are NR4A1-regulated genes that maintain low ROS and ER stress levels in Panc-1 cells, and the former gene was consistently more active in repetitive studies. Figure 6A shows that siNR4A1i and DIM-C-pPhOH decreased TXNDC5 expression in Panc-1 cells, and we also observed induction of CHOP mRNA by DIM-C-pPhOH (Fig. 6A) .
Moreover, DIM-C-pPhOH also decreased expression of TXNDC5 and induced markers of ER stress in the presence of leptomycin B, a nuclear export inhibitor ( Suppl Fig. S4A) ; DIM-C-pPhOH also did not induce nuclear export of NR4A1 (Suppl. Fig. S4B ), confirming that these responses were nuclear NR4A1-dependent. The TXNDC5 promoter has a putative NBRE at -348 and, in Panc-1 cells transfected with the pTXNDC5 luciferase reporter gene construct containing a -1444 to +25 TXNDC5 promoter insert, both siNR4A1 and DIM-C-pPhOH decreased luciferase activity (Fig. 6B) . Results of a ChIP assay demonstrated that NR4A1 bound the region containing the NBRE and treatment with DIM-C-pPhOH resulted in loss of NR4A1 binding to this site. This was accompanied by decreased binding of pol II (Fig. 6C, left panel) which is consistent with the decreased expression of TXNDC5 after treatment of Panc-1 cells with DIM-C-pPhOH (Fig. 6A) .
We also investigated NR4A1 binding to the NBRE of the TXNDC5 promoter using a nonradioactive ZZ transcription factor DNA binding assay, and the results (Fig. 6C, right panel) show that NR4A1 bound to the promoter region of TXNDC5 which contains the NBRE. Panc inhibited pancreatic and lung cancer cell proliferation, and DIM-C-pPhOH also inhibited tumor cell growth. Mechanistic studies showed that NR4A1 regulated expression of pro-survival and growth promoting genes through p300-NR4A1-Sp1 complex interactions with GC-rich gene promoter sequences (e.g. survivin) (19) , and NR4A1 also activated mTOR (20) by inhibiting the function of p53 (25) . Knockdown of NR4A1 by RNAi or inactivation of the receptor by DIM-CpPhOH reversed these responses, resulting in inhibition of cell and tumor growth, induction of apoptosis and inhibition of mTOR (19, 20) . However, microscopic examination of Panc-1 cells transfected with siNR4A1 or treated with DIM-C-pPhOH showed that NR4A1 was important for regulating stress levels since loss of this receptor resulted in significant loss and fragmentation of ER structure ( Fig. 2A) , indicative of ER stress.
We initially used a proteomics approach to identify stress-related gene products that are modulated after silencing NR4A1 (Figs. 1B and 1C) , and both siNR4A1 and DIM-C-pPhOH induced several prototypical ER stress-related genes. Analysis of the induced and repressed proteins by mass spectrometry demonstrated that NR4A1 silencing in Panc-1 cells resulted in induction of the stress proteins GRP78 and ERp60 and several other classes of proteins including the mitochondrial and cytosolic ATP5A and PGK1 proteins, respectively (Fig. 1D) .
NR4A1 silencing or treatment with DIM-C-pPhOH induced several other ER stress-related genes including ATF4, XBP-1s and CHOP as well as several markers of apoptosis that are associated with activation of ER stress (26) (27) (28) (Figs. 2B and 4A) . Moreover, many of the same markers of ER stress and apoptosis were also induced in L3.6pL pancreatic, MCF-7 breast, and RKO colon cancer cells transfected with siNR4A1 (Figs. 2C and 2D) , suggesting that NR4A1 serves as an important regulator (inhibitor) of ER stress in cancer cells. 
Based on results of CHOP silencing (Fig. 3A) , it was also evident that this gene product plays a critical role in siNR4A1 and DIM-C-pPhOH-induced ER stress and subsequent induction of cleaved caspases and PARP. Studies with several anticancer agents have demonstrated a direct linkage between drug-induced ROS and ROS-dependent induction of CHOP and downstream responses including apoptosis (30) (31) (32) . For example, the polyherbal formulation zyflamend induces ROS and ER stress (including CHOP) in colon and pancreatic cancer cells (33) and, using HCT116 colon cancer cells as a model, it was shown that cotreatment with antioxidants reverse zyflamend-induced CHOP and apoptosis. The observations are consistent with our data showing that both siNR4A1 and DIM-C-pPhOH induced ROS in Panc-1 cells (Figs.
3B and 4C) and the antioxidant GSH significantly inhibited induction of CHOP and other markers of ER stress and apoptosis (Figs. 3D and 4D ). These results suggest that NR4A1 attenuates stress levels in pancreatic cancer cells by regulating ROS metabolism and production. GSH only partially protected against NR4A1-dependent stress induced by DIM-C-pPhOH since C-DIM compounds induce stress via direct perturbation of mitochondria (34, 35) .
Results of gene array studies showed that only three ROS metabolism genes were suppressed in Panc-1 cells transfected with siNR4A1 and these include IDH1, GLRX and TXNDC5 (Fig. 5A ). IDH1 plays a critical role in the citric acid cycle and the generation of reducing equivalents, and the relative expression of wild-type and mutant IDH1 have both functional and prognostic significance in cancer (36, 37) . Glutaredoxin (GLRX) is a thioredoxin that contributes to the cellular redox status and some GLRX genes are overexpressed in human lung and breast tumors (38, 39) . TXNDC5 is a member of the thioredoxin family of ER proteins that contain a decreases expression of all three genes; however, GLRX protein levels are low and knockdown of GLRX by RNAi does not activate ER stress or apoptosis, whereas silencing IDH1 and TXNDC5 induces ER stress and apoptosis (Figs. 6A and 6B) . Thus, NR4A1 regulation of IDH1 and TXNDC5 serves to maintain homeostatic levels of ROS in Panc-1 cells, and silencing of IDH1 or TXNDC5
by RNAi induces markers of ER stress and apoptosis (Figs. 5C and 5D ) and mimics the effects of siNR4A1 or treatment of these cells with DIM-C-pPhOH (Figs. 4A and 4D) . Induction of ER stress and apoptosis markers were more pronounced in Panc-1 cells transfected with siTXNDC5 vs. siIDH1 ( Fig. 5C and 5D ), and results of ChIP assays and transfection with the TXNDC5 promoter construct confirmed that TXNDC5 is directly regulated by NR4A1. The parallel results observed after knockdown of NR4A1 or TXNDC5 or after treatment with the NR4A1 antagonist (DIM-CpPhOH) suggest that regulation of TXNDC5 expression by NR4A1 is an important pro-oncogenic function of this receptor which serves to maintain sufficiently low stress levels that facilitate cancer cell growth and survival.
TXNDC5 expression is upregulated in non-small cell lung cancer, colorectal adenomas and tumors of the cervix, uterus and stomach (compared to non-tumor tissue) (41, (43) (44) (45) , and overexpression of TXNDC5 in gastric cancer cells increased proliferation and migration and decrease apoptosis (46) . Although data mining of pancreatic cancer patient arrays did not detect higher TXNDC5 mRNA expression in tumor vs. non-tumor tissue (data not shown),
results of this study demonstrate that TXNDC5 is an important NR4A1-regulated gene that significantly contributes to the pancreatic cancer cell phenotype. Thus, NR4A1 inactivates p53 to activate mTOR signaling (20) , regulates expression of pro-survival genes with GC-rich promoters (e.g. survivin and bcl-2) (19), and regulates expression of genes such as TXNDC5 to 
